BVF INC/IL - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$11,517,000
-71.0%
300,000
-88.3%
0.31%
-78.6%
Q1 2023$39,721,110
-12.6%
2,561,0000.0%1.45%
-24.3%
Q4 2022$45,457,750
+237.7%
2,561,000
+101.1%
1.92%
+280.6%
Q2 2021$13,461,000
-26.6%
1,273,516
+11.3%
0.50%
-26.7%
Q1 2021$18,350,000
-22.8%
1,144,016
+122.4%
0.69%
-26.4%
Q4 2020$23,759,000
-43.7%
514,370
-57.1%
0.94%
-59.3%
Q3 2020$42,173,000
+59.1%
1,198,427
+10.1%
2.30%
+40.6%
Q2 2020$26,504,000
+70.3%
1,088,479
+8.8%
1.63%
+12.6%
Q1 2020$15,565,000
-1.8%
999,9960.0%1.45%
+20.7%
Q4 2019$15,850,000999,9961.20%
Other shareholders
IMMUNOVANT INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,510,412$264,291,0006.36%
Ghost Tree Capital, LLC 525,000$18,475,0005.34%
Pinz Capital Management, LP 199,100$7,006,0002.56%
ACUTA CAPITAL PARTNERS, LLC 250,000$8,798,0002.39%
BVF INC/IL 1,198,427$42,173,0002.30%
Cormorant Asset Management, LP 1,637,951$57,639,0002.22%
Vivo Capital, LLC 1,042,460$36,684,0002.12%
Parkman Healthcare Partners LLC 150,151$5,284,0001.40%
MANGROVE PARTNERS IM, LLC 230,307$8,105,0001.02%
Ikarian Capital, LLC 321,887$11,328,0000.82%
View complete list of IMMUNOVANT INC shareholders